This year, the Food and Drug Administration will consider several applications for vaccines and a monoclonal antibody to prevent respiratory syncytial virus, or RSV, illness. The common virus causes a mild cold in most people, but infants and older adults can experience serious and dangerous illness. The vaccines and preventive antibody are aimed at those […]
The post Q&A on RSV Vaccine Candidates for Older Adults appeared first on The Atlanta Voice.
